Position in NVO
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$2,831,240
+$660,859 QoQ
Shares Held
59,058
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#306
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WENDELL DAVID ASSOCIATES INC holds $121,005,454 across 9 Drug Manufacturers - General names. NVO ranks #6 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
44,419 | $53,277,485 | |
| 2 | JNJ |
Johnson & Johnson
|
100,552 | $25,537,191 | |
| 3 | ABBV |
AbbVie Inc.
|
96,228 | $24,214,813 | |
| 4 | MRK |
Merck & Co., Inc.
|
56,376 | $7,244,316 | |
| 5 | AMGN |
Amgen Inc
|
10,743 | $3,890,255 | |
| 6 | NVO |
Novo Nordisk A S
This page
|
59,058 | $2,831,240 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
13,440 | $1,698,009 | |
| 8 | PFE |
Pfizer Inc
|
65,922 | $1,587,401 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,831,240 | 59,058 | Shares | Other | 2026-07-27 | |
| 2026-03-31 | $2,170,381 | 59,058 | Shares | Other | 2026-04-23 | |
| 2025-12-31 | $3,042,267 | 59,793 | Shares | Other | 2026-01-30 | |
| 2025-09-30 | $3,653,850 | 65,847 | Shares | Other | 2025-10-30 | |
| 2025-06-30 | $5,024,794 | 72,802 | Shares | Other | 2025-07-29 | |
| 2025-03-31 | $5,331,394 | 76,777 | Shares | Other | 2025-04-18 | |
| 2024-12-31 | $6,610,378 | 76,847 | Shares | Other | 2025-01-17 | |
| 2024-09-30 | $9,123,381 | 76,622 | Shares | Other | 2024-10-21 | |
| 2024-06-30 | $11,008,394 | 77,122 | Shares | Other | 2024-07-22 | |
| 2024-03-31 | $9,915,304 | 77,222 | Shares | Other | 2024-04-22 | |
| 2023-12-31 | $8,014,271 | 77,470 | Shares | Other | 2024-01-22 | |
| 2023-09-30 | $6,408,541 | 70,470 | Shares | Other | 2023-10-20 | |
| 2023-06-30 | $5,685,897 | 35,135 | Shares | Other | 2023-07-20 | |
| 2023-03-31 | $5,681,934 | 35,704 | Shares | Other | 2023-04-19 | |
| 2022-12-31 | $5,104,889 | 37,719 | Shares | Other | 2023-01-17 | |
| 2022-09-30 | $3,757,943 | 37,719 | Shares | Other | 2022-10-18 | |
| 2022-06-30 | $4,203,028 | 37,719 | Shares | Other | 2022-07-14 | |
| 2022-03-31 | $4,227,451 | 38,068 | Shares | Other | 2022-04-22 | |
| 2021-12-31 | $4,689,216 | 41,868 | Shares | Other | 2022-01-24 | |
| 2021-09-30 | $4,015,042 | 41,819 | Shares | Other | 2021-10-19 | |
| 2021-06-30 | $3,463,889 | 41,350 | Shares | Other | 2021-07-19 | |
| 2021-03-31 | $2,858,608 | 42,400 | Shares | Other | 2021-04-20 | |
| 2020-12-31 | $2,961,640 | 42,400 | Shares | Other | 2021-01-22 | |
| 2020-09-30 | $2,943,832 | 42,400 | Shares | Other | 2020-10-20 | |
| 2020-06-30 | $2,833,647 | 43,275 | Shares | Other | 2020-07-17 | |
| 2020-03-31 | $2,629,235 | 43,675 | Shares | Other | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||